On November 9, KKT LLC announced an investment of over 100 million yen in Bioworks Inc. through the subscription of new common shares via a third-party allotment. Bioworks develops, manufactures, and sells modified polylactic acid (PLA) compounds and "PlaX™," a next-generation, plant-based synthetic fiber.
The funds raised will be allocated toward research and development, patent-related costs, personnel and outsourcing expenses, and working capital to support the growth of the PlaX™ business. In addition to financial backing, KKT will leverage its established network of enterprises and investors, as well as its expertise in business expansion, to support Bioworks' medium- to long-term development.
PlaX™ is a next-generation synthetic fiber based on plant-derived polylactic acid (PLA). By utilizing Bioworks' proprietary material modification technology, it improves upon the physical and dyeing properties of conventional PLA. Available in both filament and staple fiber forms, PlaX™ is seeing an expanding range of applications, spanning fashion, sportswear, outdoor apparel, consumer goods, and industrial materials. (Notably, Goldwin has already begun selling products made with PlaX™ material under its THE NORTH FACE and NEUTRALWORKS brands.)
According to data from Bioworks, the production of PlaX™ filaments results in 70% fewer CO2 emissions compared to polyester, while the production of staple fibers yields a 50% reduction. Furthermore, compared to the production of cotton-from raw material to yarn-PlaX™ requires 92% less water.
Investment Background
In the textile and apparel industry, addressing issues such as decarbonization, reducing reliance on petroleum-based raw materials, ensuring the efficient use of water resources, and promoting resource circularity has become critical. At the same time, for eco-friendly materials to see widespread adoption, they must offer more than just environmental benefits; they must also be practical, high-quality, aesthetically pleasing, and suitable for large-scale production.
KKT decided to make this investment because it highly values Bioworks' efforts-centered on materials technology-to reduce environmental impact and enhance industrial competitiveness. KKT also recognizes Bioworks' initiatives to establish large-scale production, processing, and sales bases in collaboration with domestic and international partners, with the goal of expanding these "Made in Japan" materials into the global market.
